Jasper Therapeutics Inc’s recently made public that its Chief Operating Officer Mahal Jeetinder Singh unloaded Company’s shares for reported $19899.0 on Dec 12 ’24. In the deal valued at $22.11 per share,900 shares were sold. As a result of this transaction, Mahal Jeetinder Singh now holds 25,009 shares worth roughly $0.15 million.
Then, Jeetinder Singh Mahal bought 900 shares, generating $20,223 in total proceeds.
Before that, Mahal Jeetinder Singh sold 900 shares. Jasper Therapeutics Inc shares valued at $19,104 were divested by the Chief Operating Officer at a price of $21.23 per share. As a result of the transaction, Mahal Jeetinder Singh now holds 25,009 shares, worth roughly $0.15 million.
BMO Capital Markets initiated its Jasper Therapeutics Inc [JSPR] rating to an Outperform in a research note published on December 06, 2024; the price target was $63. A number of analysts have revised their coverage, including JMP Securities’s analysts, who began to cover the stock in early September with a ‘”a Mkt outperform”‘ rating. BTIG Research began covering JSPR with “Buy” recommendation on July 08, 2024. Stifel started covering the stock on June 27, 2024. It rated JSPR as “a Buy”.
Price Performance Review of JSPR
On Tuesday, Jasper Therapeutics Inc [NASDAQ:JSPR] saw its stock fall -12.26% to $5.87. Over the last five days, the stock has lost -71.87%. Jasper Therapeutics Inc shares have fallen nearly -72.54% since the year began. Nevertheless, the stocks have fallen -23.96% over the past one year. While a 52-week high of $31.01 was reached on 01/02/25, a 52-week low of $6.30 was recorded on 01/14/25. SMA at 50 days reached $20.72, while 200 days put it at $21.26.
Levels Of Support And Resistance For JSPR Stock
The 24-hour chart illustrates a support level at 5.57, which if violated will result in even more drops to 5.27. On the upside, there is a resistance level at 6.45. A further resistance level may holdings at 7.02. The Relative Strength Index (RSI) on the 14-day chart is 18.31, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -10.35, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 99.88%. Stochastics %K at 1.79% indicates the stock is a buying.
How much short interest is there in Jasper Therapeutics Inc?
A steep rise in short interest was recorded in Jasper Therapeutics Inc stocks on 2024-12-31, growing by 0.26 million shares to a total of 2.32 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 2.06 million shares. There was a rise of 11.3%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on May 06, 2024 when H.C. Wainwright began covering the stock and recommended ‘”a Buy”‘ rating along with a $65 price target.
